This results in increased ZEB1 expression, which promotes EMT, characterized by downregulation of E-cadherin and upregulation of Vimentin, ultimately enhancing tumor cell invasiveness and resistance to docetaxel [84]. This evidence concerns the gene ZEB1 and neoplasm.